Sort
27,075 grants matching “cholesterol”
Mechanisms of gallbladder smooth muscle dysfunction
$542,467Brigitte Lavoie · University Of Vermont & St Agric College · R01 · FY2025 · DK
Mechanisms of gallbladder smooth muscle dysfunction
$542,467Brigitte Lavoie · University Of Vermont & St Agric College · R01 · FY2023 · DK
USING FORTILIN INHIBITORS TO BLOCK ATHEROSCLEROSIS
$542,463Ken Fujise · University Of Washington · R01 · FY2020 · HL
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
$542,443Michael Karin · University Of California, San Diego · R01 · FY2022 · CA
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
$542,443Michael Karin · University Of California, San Diego · R01 · FY2023 · CA
CASE CONTROL STUDY OF STATIN USE AND LARGE BOWEL CANCER
$542,426Boston University Medical Campus · R01 · FY2003 · CA
Aberrant ER-Mitochondria Communication in Human Mitochondrial Disease
$542,306Eric A. Schon · Columbia University Health Sciences · R01 · FY2023 · NS
Cholesterol Efflux, Foam Cell Formation and Diabetes
$542,242Columbia University Health Sciences · R01 · FY2002 · HL
Determining the Fate of Transmembrane Proteins
$542,239Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$542,085Lily Yang · Emory University · R01 · FY2021 · CA
Lipid and Protein Effects on Monolayer Stability
$542,044Joseph Anthony Zasadzinski · University Of Minnesota · R01 · FY2021 · HL
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification
$541,830Linda L. Demer · University Of California Los Angeles · R01 · FY2024 · HL
Progression of sub-clinical Atherosclerosis
$541,778Joseph F Polak · Tufts Medical Center · R01 · FY2007 · HL
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
$541,769Adrian Friedrich Gombart · Oregon State University · R01 · FY2017 · AT
Insulin Signaling, Lipoproteins and Atherosclerosis
$541,497Alan Richard Tall · Columbia University Health Sciences · P01 · FY2011 · HL
Insulin Signaling, Lipoproteins and Atherosclerosis
$541,497Alan Richard Tall · Columbia University Health Sciences · P01 · FY2010 · HL
Insulin Signaling, Lipoproteins and Atherosclerosis
$541,497Alan Richard Tall · Columbia University Health Sciences · P01 · FY2009 · HL
Insulin Signaling, Lipoproteins and Atherosclerosis
$541,497Alan Richard Tall · Columbia University Health Sciences · P01 · FY2008 · HL
Novel Pathways of Cellular Cholesterol Efflux
$541,489Alan Richard Tall · Columbia University Health Sciences · P01 · FY2008 · HL
Engineering Blood Vessels to Resist Atherosclerosis
$541,481David A Dichek · University Of Washington · R01 · FY2009 · HL
Biobehavioral Bases & Management of Metabolic Syndrome
$541,389Ronald B Goldberg · University Of Miami Coral Gables · P01 · FY2009 · HL
Maternal nutrition and oocyte programming
$541,365Kelle H Moley · Washington University · R01 · FY2016 · HD
TRANSFORMATIVE LIPID EXCHANGE APPROACHES TO STUDY MEMBRANE ORGANIZATION
$541,223Erwin London · State University New York Stony Brook · R35 · FY2020 · GM
TRANSFORMATIVE LIPID EXCHANGE APPROACHES TO STUDY MEMBRANE ORGANIZATION
$541,223Erwin London · State University New York Stony Brook · R35 · FY2021 · GM
TRANSFORMATIVE LIPID EXCHANGE APPROACHES TO STUDY MEMBRANE ORGANIZATION
$541,223Erwin London · State University New York Stony Brook · R35 · FY2019 · GM